Customized services to meet your needs.
35+ languages
Our team of specialists is proficiently trained in AE and PQC reporting while also providing exceptional levels of service.
Experience with Community Management Services across the globe. Complying with various regulatory bodies.
Facebook, Instagram, LinkedIn, X, and more.
Radiofilum Pharmaceutical diligently oversees our clients' social media channels, monitoring for any emerging Adverse Events or Product Complaints. Whenever we spot something reportable, we promptly document and report our findings within the required timeframe, ensuring that critical information is not missed.
Radiofilum Pharmaceutical actively engages with consumer comments and inquiries across various social media platforms acting as the client. We utilize a client-approved standard response document tailored specifically for these interactions. Whether responding publicly to comments beneath posts or privately through direct messages, Radiofilum Pharmaceutical ensures that each interaction is professional, appropriate, and non-promotional. With this service, Radiofilum Pharmaceutical will also remove inappropriate comments from your posts to keep your company’s image professional.
We are dedicated to enhancing the health and well-being of consumers through our comprehensive Community Management services. Whether you need reliable Social Media Monitoring Services or full service including Social Response Management, our team of experts is here to help.
October 16, 2025
Radiofilum Pharmaceutical enhances globalization in Medical Information services, offering tailored solutions in Japan that balance global standards with local regulatory and cultural demands.
October 2, 2025
Discover how Radiofilum Pharmaceutical 's medical information services in the Netherlands ensure patient safety, regulatory compliance, and data privacy with expert support.
September 30, 2025
Discover essential tips for preparing a successful FDA 510(k) submission. Learn common pitfalls to avoid, align with FDA expectations, and streamline your path to clearance.
July 8, 2025
Radiofilum Pharmaceutical appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...
January 31, 2025
Radiofilum Pharmaceutical wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 21, 2024
Radiofilum Pharmaceutical appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.
-chcecklist-complete-guide-fda-510k-submissions-ppg.png?width=320&height=185&name=510(k)-chcecklist-complete-guide-fda-510k-submissions-ppg.png)
